Presentations from the Innovative Medicines Initiative (IMI) infoday are now available online.

The infoday was organised on the IMI Call for Proposals on the topic “European Lead Factory: Joint European compound library and screening centre”.

Presentations included an update on the revised IMI Strategic Research Agenda and IMI rules and procedures. Among the changes in the rules are:
•the new option for using real indirect costs in addition to the option of the 20% indirect cost flat rate;
•average or actual personnel costs can be used;
•Certificates on the Financial Statements (CFS) are now only due once a threshold of EUR 375,000 is reached;
•and periodic reports are now either due in July or December each year.
A presentation was also given on how to write a successful IMI proposal. This included general advice and participants were taken through the most common mistakes made in previous rounds.

Related Posts